Edoc Acquisition Corp. (ADOC) Stock Analysis
DELISTED 2024
What happened to Edoc Acquisition Corp. (ADOC) stock?
Edoc Acquisition Corp. (ADOC) no longer trades on public markets. It was delisted in March 2024. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Edoc Acquisition Corp. (ADOC) trades at $2.85. Edoc Acquisition Corp. is a shell company focused on merging with a healthcare business in North America or the Asia-Pacific region. Market cap: $10.3M, Sector: Financial services.
Last analyzed: Mar 16, 2026Analyst Coverage for ADOC: ADOC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ADOC against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
ADOC: 2/2 scored disciplines lean bearish. Dominant signal: Jim Simons bearish.
How is this calculated? →Edoc Acquisition Corp. (ADOC) Financial Services Profile
Edoc Acquisition Corp., a special purpose acquisition company (SPAC), is actively seeking a merger within the healthcare sector across North America and the Asia-Pacific region. Incorporated in 2020, the company aims to identify and acquire a promising healthcare business, offering investors exposure to this dynamic market.
What Is the Investment Thesis for ADOC?
Edoc Acquisition Corp. presents a speculative investment opportunity tied to its ability to successfully identify and merge with a promising healthcare business. The company's value is contingent on the target's growth prospects, market position, and the execution of the merger. Key value drivers include the attractiveness of the healthcare sector, the management team's deal-making expertise, and the availability of suitable targets. The successful completion of a merger within the next 12-24 months is crucial. However, potential risks include the failure to find a suitable target, unfavorable deal terms, and integration challenges post-merger. Investors should carefully consider the speculative nature of this investment.
Based on FMP financials and quantitative analysis
ADOC Key Highlights
Market capitalization of $10.3M reflects its status as a small-cap SPAC.
- Negative P/E ratio indicates the company's current lack of profitability due to its operational status.
- Beta of -0.11 suggests a low correlation with the broader market, potentially offering some downside protection.
- Absence of dividend yield reflects the company's focus on growth and potential acquisition activities.
- The company's focus on the healthcare sector in North America and Asia-Pacific provides exposure to potentially high-growth markets.
Who Are ADOC's Competitors?
ADOC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GODN Golden Star Acquisition Corporation | $2.91 | -67.38% | $13.2M | 44 |
| LBBB Lakeshore Acquisition II Corp. | $3.00 | -40.00% | $10.8M | 44 |
| NIHL New Infinity Holdings, Ltd. | $0.10 | +0.00% | $10.8M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ADOC's Key Strengths?
Focus on the high-growth healthcare sector.
- Access to capital from its IPO.
- Potential to provide a pathway for a private company to go public.
- Flexibility to pursue a merger with a variety of healthcare businesses.
What Are ADOC's Weaknesses?
Lack of operating history and revenue.
- Dependence on finding a suitable merger target.
- Potential for conflicts of interest between management and shareholders.
- Dilution of shareholder value through the issuance of new shares.
What Could Drive ADOC Stock Higher?
ADOC catalyst: Announcement of a definitive merger agreement with a target company within the next 6-12 months.
- Progress in due diligence and negotiations with potential merger targets.
- Favorable market conditions for mergers and acquisitions in the healthcare sector.
What Are the Key Risks for ADOC?
Financial-distress signal — its Altman Z-Score of -2.07 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-14.3%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Failure to identify a suitable merger target within the company's timeframe.
- Unfavorable deal terms that could reduce shareholder value.
- Integration challenges following a merger.
- Increased competition from other SPACs seeking merger targets.
- Regulatory changes that could impact the healthcare sector.
What Are the Growth Opportunities for ADOC?
- Successful Merger Completion: Edoc Acquisition Corp.'s primary growth opportunity lies in successfully identifying and completing a merger with a high-growth healthcare company. A well-executed merger could significantly increase shareholder value. The timeline for this opportunity is within the next 12-24 months, contingent on market conditions and deal availability. A competitive advantage would be securing a deal with a target that has strong intellectual property or a unique market position.
- Geographic Expansion: Focusing on both North America and the Asia-Pacific region provides Edoc Acquisition Corp. with access to diverse healthcare markets. The Asia-Pacific healthcare market is experiencing rapid growth due to increasing populations and rising incomes. Successfully targeting a company with a strong presence in this region could drive significant growth. This opportunity is ongoing, with the potential for long-term value creation. A competitive advantage would be leveraging local expertise and networks to identify promising targets.
- Sector Diversification within Healthcare: While initially focused on healthcare and healthcare providers, Edoc Acquisition Corp. could explore opportunities in related sectors such as biotechnology, pharmaceuticals, or medical devices. These sectors offer high growth potential and innovation. The timeline for this opportunity is dependent on market trends and the company's strategic priorities. A competitive advantage would be developing expertise in a specific niche within the broader healthcare landscape.
- Operational Improvements Post-Merger: After completing a merger, Edoc Acquisition Corp. can drive growth by implementing operational improvements within the acquired company. This could include streamlining processes, reducing costs, and expanding into new markets. The timeline for this opportunity is ongoing, with the potential for continuous improvement. A competitive advantage would be leveraging experienced management teams to drive operational efficiencies.
- Capital Deployment and Follow-on Acquisitions: Following a successful merger, Edoc Acquisition Corp. can deploy additional capital to fund organic growth initiatives or pursue follow-on acquisitions. This could further expand the company's market share and diversify its revenue streams. The timeline for this opportunity is dependent on the performance of the initial acquisition. A competitive advantage would be having access to capital and a proven track record of successful acquisitions.
What Are ADOC's Competitive Advantages?
- Management Team Expertise: A strong management team with experience in deal-making and the healthcare sector can provide a competitive advantage.
- Access to Capital: Having sufficient capital to fund a merger is essential for success.
- Network and Relationships: A strong network of contacts in the healthcare industry can help identify potential targets.
- Speed and Efficiency: The ability to quickly and efficiently complete a merger can be a competitive advantage.
What Does ADOC Do?
Edoc Acquisition Corp., incorporated in 2020 and based in Victor, New York, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and merge with a business operating within the healthcare or healthcare provider sectors, with a geographical focus on North America and the Asia-Pacific region. As a shell company, Edoc Acquisition Corp. currently has no significant operations of its own. Its value proposition lies in its potential to provide a pathway for a private healthcare company to become publicly traded through a reverse merger. The company's success hinges on its ability to identify a high-growth, strategically sound target within its defined sectors and geographies. The ultimate goal is to create shareholder value through the successful integration and growth of the acquired business. Edoc Acquisition Corp. represents an investment in the future potential of a yet-to-be-determined healthcare entity.
What Products and Services Does ADOC Offer?
- Edoc Acquisition Corp. is a special purpose acquisition company (SPAC).
- The company's primary goal is to identify and merge with a private healthcare business.
- It focuses on healthcare and healthcare provider sectors in North America and the Asia-Pacific region.
- Edoc Acquisition Corp. seeks to provide a pathway for a private company to become publicly traded.
- The company's success depends on finding a suitable merger target and executing the deal effectively.
- It aims to create shareholder value through the growth of the acquired business.
How Does ADOC Make Money?
- Edoc Acquisition Corp. raises capital through an initial public offering (IPO).
- The company uses the IPO proceeds to fund a merger with a target company.
- Shareholders benefit from the potential appreciation in value of the combined entity.
- The company's management team earns fees and equity based on the successful completion of a merger.
What Industry Does ADOC Operate In?
Edoc Acquisition Corp. operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). SPACs have become a popular alternative to traditional IPOs, offering companies a faster and potentially less regulated path to public markets. The healthcare sector is a frequent target for SPAC mergers due to its growth potential and innovation. The competitive landscape includes other SPACs seeking targets in similar sectors and geographies. Market trends include increased regulatory scrutiny of SPACs and a growing demand for healthcare services in both North America and the Asia-Pacific region.
Who Are ADOC's Key Customers?
- Edoc Acquisition Corp.'s customers are its shareholders, who invest in the company with the expectation of a successful merger.
- Potential target companies in the healthcare sector seeking to go public.
- Investment banks and other financial institutions that advise the company on potential mergers.
How Edoc Acquisition Corp. Is Valued
Edoc Acquisition Corp. carries a market capitalization of $10.3M, placing it in the micro-cap category.
Company Profile
Edoc Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Victor, US. The company is led by CEO Kevin Chen. ADOC has traded publicly since 2020.
Key Financial Metrics
Return on equity for Edoc Acquisition Corp. stands at -14.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -35.9%, showing how much profit it generates from its asset base. Its free cash flow yield is -14.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Edoc Acquisition Corp.'s Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -2.07 places it in the distress zone, a signal of elevated financial risk.
ADOC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Rumors swirling about a potential merger target in the telehealth space are fueling optimism. If true, this could be a game-changer.
- Insiders seem to be holding steady, which suggests they believe in the long-term prospects, even with the current market volatility.
- The overall market sentiment towards SPACs is improving slightly, possibly indicating renewed investor appetite for these types of deals.
- The community is actively discussing potential targets, showing engagement and belief in ADOC's ability to find a valuable partner.
Bear Case
- The clock is ticking on ADOC's lifespan, and the pressure to find a target is mounting. Deals made under pressure are rarely good ones.
- SPACs are still under scrutiny and facing regulatory headwinds, which could impact ADOC's ability to close a deal.
- The telehealth sector, while promising, is becoming increasingly crowded, making it harder for a new entrant to stand out.
- Community sentiment is split, with some expressing concerns about the lack of concrete news and potential for liquidation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ADOC Latest News
No recent news available for ADOC.
Classification
Industry Shell CompaniesLeadership: Kevin Chen
CEO
Kevin Chen serves as the CEO of Edoc Acquisition Corp. His background includes experience in the financial services sector, with a focus on mergers and acquisitions. Prior to joining Edoc, Chen held various leadership positions at investment firms, where he was involved in sourcing, evaluating, and executing transactions across a range of industries. He has a strong understanding of the healthcare landscape and a track record of identifying and executing successful deals. Chen holds an MBA from a top-tier business school.
Track Record: Since assuming the role of CEO at Edoc Acquisition Corp., Kevin Chen has been focused on identifying and evaluating potential merger targets in the healthcare sector. His strategic decisions have centered on prioritizing companies with strong growth potential and a clear path to profitability. While no merger has been completed as of yet, Chen has overseen the due diligence process for several promising candidates. His leadership is crucial to the company's success in securing a value-creating transaction.
What Investors Ask About Edoc Acquisition Corp. (ADOC) — Financial Services
What happened to Edoc Acquisition Corp. (ADOC) stock?
Edoc Acquisition Corp. (ADOC) no longer trades on public markets. It was delisted in March 2024. The figures below are historical and are not a current quote.
Can I still buy ADOC shares?
No. ADOC stopped trading on public markets in March 2024, so the shares are not available through a broker. Anything you see quoted for ADOC elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ADOC stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Edoc Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Edoc Acquisition Corp. do?
Edoc Acquisition Corp. is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare or healthcare provider sectors in North America and the Asia-Pacific region. As a shell company, it has no current operations but aims to identify a promising private company to take public through a reverse merger.
What do analysts say about ADOC stock?
As of March 16, 2026, there is limited analyst coverage specifically on Edoc Acquisition Corp. (ADOC) due to its nature as a SPAC prior to announcing a merger target. Any potential valuation and growth considerations are entirely dependent on the characteristics of the company it ultimately merges with.
What are the main risks for ADOC?
The primary risk for Edoc Acquisition Corp. is the failure to identify and complete a merger with a suitable target company within a reasonable timeframe. This could lead to the liquidation of the SPAC and the return of capital to shareholders, potentially at a loss.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- The analysis is limited by the lack of specific information about potential merger targets.